Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
12Customers
1Debt Items
20Related Chains
Source-Backed Evidence Depth
MediWound Ltd. (MDWD) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
18Total relationships
2Distinct source URLs
5High confidence
0.726Average confidence
2026-09-14Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Reciprocal relationship from PRFX graph: Reciprocal relationship from MDWD graph: Reciprocal relationship from PRFX graph: s, liabilities and expenses, as well as related disclosure of contingent ass…
SNNUF
Smith & Nephew plc
72%
Reciprocal relationship from SNNUF graph: Reciprocal relationship from MDWD graph: es have obtained marketing authorization. Our additional distributors have filed or are in the process of filing for…
SNNUF
Smith & Nephew plc
72%
es have obtained marketing authorization. Our additional distributors have filed or are in the process of filing for market authorization in their respective territories and are expected to launch Ne…
Reciprocal relationship from VCEL graph: ew manufacturing facility in Burlington, Massachusetts, the ability to sustain profitability, contributions to adjusted EBITDA, the expected target surgeon au…
MediWound Ltd. Customers
Ticker
Name
Confidence
Evidence
VERICEL
VERICEL
90%
The success of our business depends largely on Vericel's success in commercializing NexoBrid.
MEDICAL-TECHNOLOGY-ENTERPRISE-CONSORTIUM
MEDICAL-TECHNOLOGY-ENTERPRISE-CONSORTIUM
85%
In February 2022, the Company entered into a contract with the U.S. Department of War (the "DoW") through the Medical Technology Enterprise Consortium (MTEC) to advance the development of a temperatu…
U-S-DEPARTMENT-OF-WAR
U-S-DEPARTMENT-OF-WAR
85%
In February 2022, the Company entered into a contract with the U.S. Department of War (the "DoW") through the Medical Technology Enterprise Consortium (MTEC) to advance the development of a temperatu…
SNNUF
Smith & Nephew plc
72%
Reciprocal relationship from SNNUF graph: Reciprocal relationship from MDWD graph: Reciprocal relationship from SNNUF graph: Reciprocal relationship from MDWD graph: es have obtained marketing author…
SNNUF
Smith & Nephew plc
72%
es have obtained marketing authorization. Our additional distributors have filed or are in the process of filing for market authorization in their respective territories and are expected to launch Ne…
BIOPHARMAX-GROUP-LTD
BIOPHARMAX-GROUP-LTD
62%
as long been the subject of considerable discussion in Congress and among policymakers, and it is possible that Congress could enact additional laws that negatively affect the pharmaceutical industry…
CLAL-BIOTECHNOLOGY-INDUSTRIES-LTD
CLAL-BIOTECHNOLOGY-INDUSTRIES-LTD
62%
. g. Deferred taxes: The Company did not recognize deferred tax assets for temporary differences because their utilization in the foreseeable future is not probable. F - 44 MEDIWOUND LTD. AND ITS SUB…
CO-LLC
CO-LLC
62%
compared to approximately $20.2 million for the year ended December 31, 2024. The change is primarily attributable to the U.S. government shutdown, which resulted in delays in budget approvals and th…
MEDIWOUND-GERMANY-GMBH
MEDIWOUND-GERMANY-GMBH
62%
as long been the subject of considerable discussion in Congress and among policymakers, and it is possible that Congress could enact additional laws that negatively affect the pharmaceutical industry…
MEDIWOUND-UK-LIMITED
MEDIWOUND-UK-LIMITED
62%
as long been the subject of considerable discussion in Congress and among policymakers, and it is possible that Congress could enact additional laws that negatively affect the pharmaceutical industry…
MEDIWOUND-US-INC
MEDIWOUND-US-INC
62%
as long been the subject of considerable discussion in Congress and among policymakers, and it is possible that Congress could enact additional laws that negatively affect the pharmaceutical industry…
PREFERRED-TECHNOLOGY-COMPANY
PREFERRED-TECHNOLOGY-COMPANY
62%
compared to approximately $20.2 million for the year ended December 31, 2024. The change is primarily attributable to the U.S. government shutdown, which resulted in delays in budget approvals and th…
MediWound Ltd. Debt Obligations
Instrument
Description
Confidence
Evidence
MDWD-DEBT
Debt stack $8.1M
90%
Market cache reports total debt of $8.1M.
MediWound Ltd. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for MediWound Ltd..
MediWound Ltd. Ownership
Holder
Name
Confidence
Evidence
MDWD-OWNER-INVESTOR-AB
INVESTOR AB
90%
13F overlay lists INVESTOR AB as top holder; 76 tracked holders.
